Atopic dermatitis (AD) is a chronic disease that affects an increasing number of children and adults. The skin is dry and irritated, and the itching can be so severe that it interferes with sleep and ...

Nektar Therapeutics is rated Strong Buy based on promising Phase 2b maintenance data for REZPEG in atopic dermatitis. REZPEG's unique mechanism expands regulatory T cells, aiming for durable immune ...

ORLANDO, Fla. — In a phase 3 atopic dermatitis (AD) trial, rocatinlimab, a novel therapy that targets T cells expressing the OX40 receptor, showed efficacy on both coprimary and key secondary ...

Spa treatment. Image by IQP - CC BY-SA 3.0, Spa treatment. Image by IQP - CC BY-SA 3.0, Atopic dermatitis (AD) is experiencing a shift in treatment management with recent drug approvals that address ...

Please provide your email address to receive an email when new articles are posted on . Rezpegaldesleukin is a first-in-class interleukin-2 receptor agonist that proliferates and activates regulatory ...

—Shared pathogenesis between atopic dermatitis, vitiligo, and alopecia areata supports a unified approach that targets these common mechanisms, promising better treatment options for these ...

In a study of adults with atopic dermatitis (AD), twice-weekly bleach baths led to significant improvements in itching, disease severity, and skin barrier function. Bleach baths' exact mechanism of ...

Your skin endures constant scratches, scrapes, and bumps, yet the bacterium Staphylococcus aureus can cling on through it all. Although usually harmless, S. aureus can cause serious infections and ...

WAYNE, Pa., June 02, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for ...